OriGene Logo

Customer Login

Checkout as a new customer

Creating an account has many benefits:

  • See order and shipping status
  • Track order history
  • Check out faster
Create an Account

Ndufa13 Mouse shRNA Plasmid (Locus ID 67184)

Be the first to review this product
SKU
TR503841
Ndufa13 - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector, 5µg of each construct provided
  $883.00
2 Weeks*

Frequently Bought Together (1)

TF81001 TurboFectin Transfection Reagent (1 mL in 1 vial)
1 ml in 1 vial
$530.00

Other products for "Ndufa13 or NM_023312"

Specifications
Specifications
Product Data
Locus ID 67184
Synonyms 2700054G14Rik; AU022060; CDA016; CGI-39; GRIM-19; Grim19
Vector pRS
E. coli Selection Ampicillin
Mammalian Cell Selection Puromycin
Format Retroviral plasmids
Components Ndufa13 - Mouse, 4 unique 29mer shRNA constructs in retroviral untagged vector(Gene ID = 67184). 5µg purified plasmid DNA per construct
29-mer scrambled shRNA cassette in pRS Vector, TR30012, included for free.
RefSeq BC034899, BC037149, BC055435, NM_023312, NM_023312.1, NM_023312.2, NM_023312.3
UniProt ID Q9ERS2
Summary May play a role in spermiogenesis and oogenesis.UniProtKB/Swiss-Prot Function
shRNA Design These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Storage Store at -20°C
Shipping Ambient
Reviews
Write Review
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation
Ni, Yan, Zhou et al
Cancer Chemother. Pharmacol. (2018)
AI Summary: OriGene’s pRS-GRIM19 shRNA and pRS vector were used to generate GRIM19-depleted UMUC-3 bladder cancer cells, enabling the study of GRIM19’s role in cisplatin resistance.
Snippet: To generate the GRIM19-depleted cells, UMUC-3 cells were transfected with pRS-GRIM19 shRNA or pRS vec- tor (OriGene, Beijing, China) using ViaFect . 1 day after transfection, the transfected cells were selected with 1.0 µg/ml puromycin (Sigma-Aldrich) for
Showing 1-1 of 1 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products